Use this URL to cite or link to this record in EThOS: http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.501741
Title: Investigating warfarin variabilty : the contribution of clinical, genetic, and enviromental factors
Author: Al-Zubiedi, Sameh A.
Awarding Body: University of Liverpool
Current Institution: University of Liverpool
Date of Award: 2009
Availability of Full Text:
Access through EThOS:
Abstract:
Warfarin is the most widely used oral anticoagulant for the prevention and treatment of various cardiovascular diseases. However, its complications represent an important clinical problem. The drug has a very low therapeutic index and there is significant interpatient and inter-iscmer variability in both pharmacokinetics and pharmacodynamics; these are affected by a large number of genetic and non-genetic factors. Genetic variation in CYP2C9 and VKORCl has been most extensively studied in relation to warfarin dose requirements.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.501741  DOI: Not available
Share: